Treating chronic hepatitis C in general practice

Kate Muller; Mohamed Hasan

doi:10.31128/AJGP-06-21-6029

Treating chronic hepatitis C in general practice

Kate Muller, Mohamed Hasan

College of Medicine and Public Health

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Background Hepatitis C virus (HCV) infection continues to result in significant morbidity mortality in Australia. Eradication of challenge, with many the new era of direct-acting antivirals (DAAs), higher viral eradication rates are attainable, and access to treatment can be expanded by treating most patients practice, moving treatment by a gastroenterologist, physician. Currently available DAAs are pan-genotypic, well tolerated and safe; undertaken in general practice.

Original language	English
Pages (from-to)	697-701
Number of pages	5
Journal	Australian Journal of General Practice
Volume	50
Issue number	10
DOIs	https://doi.org/10.31128/AJGP-06-21-6029
Publication status	Published - Oct 2021

Keywords

Blood-borne Virus
Hepatitis C
Infectious disease
Liver
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.31128/AJGP-06-21-6029Licence: In Copyright

Cite this

@article{1193259fe1ad4123a3670801a4defaee,

title = "Treating chronic hepatitis C in general practice",

abstract = "Background Hepatitis C virus (HCV) infection continues to result in significant morbidity mortality in Australia. Eradication of challenge, with many the new era of direct-acting antivirals (DAAs), higher viral eradication rates are attainable, and access to treatment can be expanded by treating most patients practice, moving treatment by a gastroenterologist, physician. Currently available DAAs are pan-genotypic, well tolerated and safe; undertaken in general practice.",

keywords = "Blood-borne Virus, Hepatitis C, Infectious disease, Liver, Pharmacology",

author = "Kate Muller and Mohamed Hasan",

year = "2021",

month = oct,

doi = "10.31128/AJGP-06-21-6029",

language = "English",

volume = "50",

pages = "697--701",

journal = "Australian Journal of General Practice",

issn = "2208-794X",

publisher = "Royal Australian College of General Practitioners",

number = "10",

}

TY - JOUR

T1 - Treating chronic hepatitis C in general practice

AU - Muller, Kate

AU - Hasan, Mohamed

PY - 2021/10

Y1 - 2021/10

N2 - Background Hepatitis C virus (HCV) infection continues to result in significant morbidity mortality in Australia. Eradication of challenge, with many the new era of direct-acting antivirals (DAAs), higher viral eradication rates are attainable, and access to treatment can be expanded by treating most patients practice, moving treatment by a gastroenterologist, physician. Currently available DAAs are pan-genotypic, well tolerated and safe; undertaken in general practice.

AB - Background Hepatitis C virus (HCV) infection continues to result in significant morbidity mortality in Australia. Eradication of challenge, with many the new era of direct-acting antivirals (DAAs), higher viral eradication rates are attainable, and access to treatment can be expanded by treating most patients practice, moving treatment by a gastroenterologist, physician. Currently available DAAs are pan-genotypic, well tolerated and safe; undertaken in general practice.

KW - Blood-borne Virus

KW - Hepatitis C

KW - Infectious disease

KW - Liver

KW - Pharmacology

UR - http://www.scopus.com/inward/record.url?scp=85117269759&partnerID=8YFLogxK

U2 - 10.31128/AJGP-06-21-6029

DO - 10.31128/AJGP-06-21-6029

M3 - Article

C2 - 34590084

AN - SCOPUS:85117269759

SN - 2208-794X

VL - 50

SP - 697

EP - 701

JO - Australian Journal of General Practice

JF - Australian Journal of General Practice

IS - 10

ER -

Treating chronic hepatitis C in general practice

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this